KLF4 and head and neck squamous cell carcinoma: Our recent evidence suggests that in a background of high and stable KLF4 protein levels, the antagonist Slug cannot be activated (HPV-positive HNSCC tissue samples, UPCI-SCC-90 cells) [4,9], and in this condition HNSCC is sensitive to Cisplatin treatment.